Home » Topics » Regulatory » Patents

Patents
RSS

Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents

Oct. 26, 1998

New Na+/H+ exchange inhibitors in development at HMR

Oct. 26, 1998

New compounds from Astra for pain, GI disorders and spinal injuries

Oct. 23, 1998

New series of antiischemic/antiarrhythmic compounds developed at HMR

Oct. 23, 1998

Potent GABA-B antagonists described for CNS disorders by Novartis

Oct. 23, 1998

Monosaccharide conjugates of pyrimethamine and other therapeutic agents patented

Oct. 23, 1998

Astra patents novel immunosuppressive agents

Oct. 22, 1998

New antiplatelet agents in the pipeline at Astra

Oct. 22, 1998

Dopaminergic and serotonergic agents synthesized at Lundbeck

Oct. 22, 1998

DuPont discloses heteroaromatic factor Xa inhibitors

Oct. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...